Naturhouse Health Sa · BME:NTH

Naturhouse Health Sa — FY2019 Earnings Presentation

13 slides from Naturhouse Health Sa's earnings presentation, Feb 28, 2020

  1. Slide 1: 2019 Results

    2019 Results February 28th 2020

  2. Slide 2: Disclaimer

    Disclaimer This document has been prepared by NATURHOUSE HEALTH S.A. (“NATURHOUSE” or the “Company”) for its exclusive use during the presentations announcing the Company’s results of 3Q19. NATURHOUSE does not authorise its dissemination, publication or use by any other person, whether physical or l

  3. Slide 3: Index

    Index ❑ Main Figures ❑ Consolidated Profit & Loss Account ❑ Quarterly Evolution ❑ Sales and EBITDA by Country ❑ Naturhouse Centres ❑ Net Cash & Dividends ❑ Consolidated Balance Sheet ❑ Strategy & Outlook ❑ Price Sensitive Information Notes for the Period 3

  4. Slide 4: Main Figures

    Main Figures The Board of Directors has proposed the final 2019 dividend payment of 0,05€/share to be paid May 8th, 2019(1),, leading to a total dividend for 2019 of 0,24€/share and reaching a payout of 107% and a per-dividend yield of 12,02%(2) Second consecutive Positive EBITDA Quarter +28.1% EBIT

  5. Slide 5: Consolidated Profit & Loss Account

    Consolidated Profit & Loss Account 2018 2019 Variation Total Sales 87.289 81.667 -5.621 Procurements -25.158 -23.841 1.318 Gross profit 62.130 57.827 -4.304 Gross profit margin 71,2% 70,8% ❑ Changes in accounting policies in 2019 with Personnel -20.709 -19.331 1.377 IFRS 16, which affects the way le

  6. Slide 6: Quarterly Evolution

    Quarterly Evolution Second consecutive Positive EBITDA Quarter In 4Q19 sales have decreased due to the comercial reestructuration of the centers, meaning the closure of 95 centers during 2019 year. Although, 4Q19 improves its EBITDA, enchaining the second positive quarter. EBITDA increased 0.1% (wit

  7. Slide 7: Sales & EBITDA by Country

    Sales & EBITDA by Country Sales according to country ❑ Turnover at the end of 2019 stands at €81.67m. 2018 2019 % ✓ The decrease in the total sales figure, € 5.62 m are explained by the closing of centres as a result of the France 35.770 32.656 -8,7% optimization plan (-95 centres compared to the en

  8. Slide 8: Naturhouse Centres

    Naturhouse Centres 2,188 centres in 28 countries -95 net closes in 2019 as part of the company’s business optimisation plan to improve the average revenue per store Total Centres +81 -77 -95 +169 +156 +64 Net openings: 2.279 2.360 2.283 2.188 2.123 1.890 1.954 -93 franchises mainly due to the compan

  9. Slide 9: Net Cash Position & Dividends

    Net Cash Position & Dividends Naturhouse maintains a solid financial position and an attractive shareholder remuneration policy Dividends (1) Net cash position 25.675 15.087 14.940 22.800 12.814 20.400 10.880 16.950 14.050 15.000 (*) 7.338 7.574 11.600 5.191 5.372 8.100 (*) -114 2012 2013 2014 2015

  10. Slide 10: Balance Sheet

    Balance Sheet 2018 2019 Intangible assets 1.412 1.296 Property, plant & equipment 3.806 9.618 Non current financial assets 882 828 ❑ Changes in accounting policies in 2019 with Investment in associated companies 3.348 3.152 IFRS 16, which affects the way leases are Deferred tax assets 150 138 record

  11. Slide 11: Strategy and Outlook

    Strategy and Outlook We are focusing on growth, discipline in terms of our spending and the goal of maintaining our leading position in the Spanish Stock Exchange in terms of our dividend policy Strategy ✓ After the experience in the development of the digital business in the British and North Ameri

  12. Slide 12: Material Facts for the period

    Material Facts for the period Material facts for the period ❑ 24 January 2019: Appointment E-Commerce Director for the united States ❑ 25 February 2019: Liquidity Contract with Rent 4 ❑28 February 2019: 2018 Final Ordinary Dividend ❑ 28 February 2019: Annual Corporate Governance Report ❑ 28 February

  13. Slide 13: Contact

    CONTACT Hugo Campillo Pinazo CFO Tel: +34 914323953 Email: accionista@naturhouse.com 13

Naturhouse Health — FY2019 Earnings Presentation on 6ix